Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GRM7 | Q14831 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL173810 | 0.89 | IDO1 (0.56) | IDO1MEN1KMT2AMAPTGRM7 | |
| SCHEMBL6153717 | 0.73 | IDO1 (0.56) | IDO1MAPTGRM7LMNAHRH3 | |
| SCHEMBL31141646 | 0.73 | IDO1 (0.56) | IDO1MAPTGRM7LMNAHRH3 | |
| SCHEMBL173391 | 0.70 | IDO1 (0.61) | IDO1MAPTGRM7LMNAHRH3 | |
| SCHEMBL173705 | 0.69 | MTNR1A (0.53) | IDO1MEN1KMT2AMAPTGRM7 | |
| SCHEMBL19977026 | 0.69 | IDO1 (0.47) | IDO1MEN1KMT2AMAPTGRM7 | |
| SCHEMBL3754299 | 0.69 | MTNR1A (0.56) | MEN1KMT2AMAPTLMNAMTNR1A | |
| SCHEMBL3428492 | 0.69 | IDO1 (0.59) | IDO1MEN1KMT2AMAPTGRM7 | |
| SCHEMBL2794675 | 0.68 | IDO1 (1.00) | IDO1MEN1KMT2AMAPTGRM7 | |
| SCHEMBL28684223 | 0.67 | MTNR1A (0.62) | IDO1KMT2AMTNR1AMTNR1BPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298138-A1 | Aminoazoline and Urea Derivatives for Combating Animal Pests | BASF SE (DE) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298138-A1 | Aminoazoline and Urea Derivatives for Combating Animal Pests | AADAT, INMT, SLC14A1 | IDO1 38/4885MEN1 972/4885KMT2A 2055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.